SCHEMBL20147971

SCHEMBL20147971

COc1ccc(CO)c(C)c1OC

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDCD1 Q15116 1/20 0.46
CD274 Q9NZQ7 1/20 0.46
PDE4A P27815 1/20 0.44
PDE4B Q07343 1/20 0.44
PDE4C Q08493 1/20 0.44
PDE4D Q08499 1/20 0.44
LMNA P02545 2/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
MAPK1 P28482 1/20 0.43
AOC3 Q16853 1/20 0.42
ALDH1A1 P00352 3/20 0.41
MEN1 O00255 1/20 0.41
TSHR P16473 1/20 0.41
KMT2A Q03164 1/20 0.41
MAPT P10636 1/20 0.40
POLB P06746 1/20 0.39
CYP1A2 P05177 1/20 0.39
CHRM2 P08172 1/20 0.39
SLC6A4 P31645 1/20 0.39
OPRD1 P41143 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4598965 0.88 MEN1 (0.51) PDCD1CD274PDE4APDE4BPDE4C
SCHEMBL697386 0.84 KMT2A (0.48) PDCD1CD274PDE4APDE4BPDE4C
SCHEMBL1340134 0.83 AOC3 (0.53) PDE4APDE4BPDE4CPDE4DLMNA
SCHEMBL13067434 0.82 SMN1; SMN2 (0.44) LMNASMN1; SMN2MAPK1AOC3ALDH1A1
SCHEMBL14539258 0.80 PDCD1 (0.39) PDCD1CD274PDE4APDE4BPDE4C
SCHEMBL11212134 0.80 AOC3 (0.42) LMNASMN1; SMN2MAPK1AOC3ALDH1A1
SCHEMBL11300908 0.80 AOC3 (0.46) PDCD1CD274PDE4APDE4BPDE4C
SCHEMBL30056339 0.80 AOC3 (0.46) PDCD1CD274PDE4APDE4BPDE4C
Ether SCHEMBL27467122 0.79 MEN1 (0.45) PDCD1CD274PDE4APDE4BPDE4C
SCHEMBL18674353 0.79 PDCD1 (0.35) PDCD1CD274PDE4APDE4BPDE4C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180134659-A1 OXINDOLE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF MUSC FOUNDATION FOR RESEARCH DEVELOPMENT 2018-05-17 US disclosed
CN-1118448-C Process for preparing benzyl-ethers CHINOIN GYOGYSZER VEGY ZETI TE (HU) 2003-08-20 CN disclosed
CN-1237954-A Process for preparation of benzyl-ethers CHINOIN GYOGYSZER VEGY ZETI TE (HU) 1999-12-08 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180134659-A1 OXINDOLE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF PARK7, OPRK1, COMT PDCD1 1676/4885CD274 3708/4885PDE4A 1214/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.